Nanomedicine News

RSS

Notice of Allowance for Alnylam’s Patent Covering Second Generation LNP Platform

Notice of Allowance for Alnylam’s Patent Covering Second Generation LNP Platform

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has declared the issuance of a notice of allowance by the United States Patent and Trademark Office (USPTO) for the patent application number 12/813,448 that covers the company’s in-house second generation lipid nanoparticle platform and the MC3 lipid.

1 Feb 2012

Report Analyzes Role of Nanotechnology in Drug Delivery

Report Analyzes Role of Nanotechnology in Drug Delivery

Research and Markets has declared the inclusion of a market report titled ‘Nanotechnology in Drug Delivery 2011-2021’ to its offering.

From Research and Markets 31 Jan 2012

Researchers Develop Novel Protein Nanoclusters to Help Advance Drug Delivery

Researchers Develop Novel Protein Nanoclusters to Help Advance Drug Delivery

A research team comprising Keith P. Johnston, Thomas M. Truskett and Jennifer Maynard from the Cockrell School of Engineering at The University of Texas at Austin has developed a novel protein formulation strategy to develop advanced drug delivery systems for treating arthritis, cancer and infectious diseases easily, efficiently and safely.

31 Jan 2012

Research and Markets Includes Report on Medical Nanotechnology Market

Research and Markets Includes Report on Medical Nanotechnology Market

Research and Markets has added the "Medical Nanotechnology Market Guide 2012" report to its catalogue.

From Research and Markets 30 Jan 2012

Cientifica Reports on Global Market for Nanotechnology in Drug Delivery

In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry...

26 Jan 2012

Novel Synthetic Nanoparticles Help Develop Personalized Vaccines

Novel Synthetic Nanoparticles Help Develop Personalized Vaccines

Duke University Medical Center researchers have developed synthetic nanoparticles capable of directly targeting lymph nodes, paving the way to optimize vaccine responses and develop customized vaccines.

From Duke University - Fitzpatrick Center for Photonics 24 Jan 2012

Multi-Chambered Nanoparticles Help Optimize Antibiotics

Multi-Chambered Nanoparticles Help Optimize Antibiotics

Scientists from Nano Med Tech are working on designing multi-chambered nanoparticles capable of treating infected cells without causing damage to healthy tissues.

24 Jan 2012

Global Nanomedicine Market to Reach $130.9 Billion by 2016

Global Nanomedicine Market to Reach $130.9 Billion by 2016

Global Information has added a business report titled ‘Nanotechnology in Medical Applications: The Global Market’ to its offering.

From Global Industry Analysts 23 Jan 2012

Novel Nanoparticles Help Advance Anti-Cancer Drug Delivery

Novel Nanoparticles Help Advance Anti-Cancer Drug Delivery

A research team led by Kit S. Lam from UC Davis has synthesized a novel class of nanoparticles to eliminate premature release of drugs, paving the way to deliver anti-cancer drugs to tumor sites accurately and efficiently.

21 Jan 2012

Novel Nanoparticle-Based Drug Delivery System for Cancer Treatment

Novel Nanoparticle-Based Drug Delivery System for Cancer Treatment

A research team headed by Dr. Xiao Yan Fat from Nano Med Tech based in Shanghai has developed a novel technique to create nanoparticles capable of acting like red blood cells.

20 Jan 2012

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.